Answers are grounded in this paper and cite their sources.
A dvances in the understanding of neurobiological and neuro psychiatric pathophysiology have opened new avenues of treatment for psychiatric patients. Historically, with a few exceptions, most psychiatric medications have been administered orally. However, many of the newer treatments require some form of special ized administration because they cannot be taken orally due to their chemical property (such as aducanumab); because there is the need to produce stable blood levels of the medication (such as brexanolone); because oral administration greatly diminished efficacy (such as oral vs IV magnesium or scopolamine), or because the treatment is focused on specific brain structures. This need for specialized administration has created a subspecialty called interventional psychiatry.
No takes yet. Share an insight, caveat, or question.
Dmitry M Arbuck (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: